Stay updated on XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded 'Medullary thyroid carcinoma' as a topic reference and included a link to the Genetic and Rare Diseases Information Center in the Resources section.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision label updated to v3.5.0; previous Revision: v3.4.3 label was removed.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2; no user-facing content appears to be affected.SummaryDifference0.0%

- Check53 days agoChange DetectedThe update is a technical revision label from v3.4.1 to v3.4.2 with no impact on study information or on-page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.1 is now active; the previous v3.4.0 revision has been replaced. The visible content remains the same.SummaryDifference0.0%

- Check68 days agoChange DetectedA glossary toggle was added; QC metadata label was updated to 'Last Update Submitted that Met QC Criteria' and a No FEAR Act Data notice appears. The revision version was bumped from v3.3.4 to v3.4.0 with minor capitalization adjustments.SummaryDifference0.1%

Stay in the know with updates to XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XL184 Efficacy in Advanced Medullary Thyroid Cancer Clinical Trial page.